CytomX Therapeutics, Inc.
USD3.16
-0.29 (-8.41%)
CEO
Sean A. McCarthy
IPO Date
2015-10-08
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.40
Prev. Close
$3.45
Day Low
$3.14
Day High
$3.41
52W Low
$1.72
52W High
$8.21
Market Cap
$0.51B
Volume
4.92M
| 118,969 |
| $6.42 |
| 19 Mar 2026 | BELVIN MARCIA | SVP, Chief Scientific Officer | S-Sale | Disposed | 31,492 | $6.42 |
| 19 Mar 2026 | Ogden Christopher | Chief Financial Officer | S-Sale | Disposed | 19,323 | $6.42 |
| 4 Feb 2026 | Lester Rachael | Chief Business Officer | A-Award | Acquired | 20,000 | $0.00 |
| 4 Feb 2026 | Lester Rachael | Chief Business Officer | A-Award | Acquired | 50,000 | $0.00 |
| 4 Feb 2026 | Lester Rachael | Chief Business Officer | A-Award | Acquired | 50,000 | $6.09 |
| 4 Feb 2026 | Chu Yu-Waye | Chief Medical Officer | A-Award | Acquired | 300,000 | $6.09 |
| 4 Feb 2026 | Chu Yu-Waye | Chief Medical Officer | A-Award | Acquired | 75,000 | $0.00 |
| 4 Feb 2026 | BELVIN MARCIA | SVP, Chief Scientific Officer | A-Award | Acquired | 250,000 | $6.09 |